PEGylated FePt–Fe3O4 composite nanoassemblies (CNAs): in vitro hyperthermia, drug delivery and generation of reactive oxygen species (ROS)
- 9 March 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 44 (19), 9103-9113
- https://doi.org/10.1039/c4dt03470h
Abstract
Schematic representation of in vitro cancer therapy using DOX loaded PEGylated FePt/Fe3O4 composite nanoassemblies (CNAs) in the presence of ACMF or H2O2.Keywords
This publication has 33 references indexed in Scilit:
- Role of different platinum precursors on the formation and reaction mechanism of FePt nanoparticles and their electrocatalytic performance towards methanol oxidationDalton Transactions, 2013
- In vitro evaluation of PEGylated mesoporous MgFe2O4 magnetic nanoassemblies (MMNs) for chemo-thermal therapyJournal of Materials Chemistry B, 2013
- Influence of excess Fe accumulation over the surface of FePt nanoparticles: Structural and magnetic propertiesJournal of Applied Physics, 2013
- pH‐Responsive Peptide Mimic Shell Cross‐Linked Magnetic Nanocarriers for Combination TherapyAdvanced Functional Materials, 2012
- A magnetically guided anti-cancer drug delivery system using porous FePt capsulesBiomaterials, 2012
- Oxide and hybrid nanostructures for therapeutic applicationsAdvanced Drug Delivery Reviews, 2011
- Doxorubicin Release Triggered by Alginate Embedded Magnetic Nanoheaters: A Combined TherapyAdvanced Materials, 2010
- Noninvasive Remote-Controlled Release of Drug Molecules in Vitro Using Magnetic Actuation of Mechanized NanoparticlesJournal of the American Chemical Society, 2010
- Strategies in the design of nanoparticles for therapeutic applicationsNature Reviews Drug Discovery, 2010
- FePt Nanoparticles as an Fe Reservoir for Controlled Fe Release and Tumor InhibitionJournal of the American Chemical Society, 2009